Details

Autor(en) / Beteiligte

• Wong, David T
• Perry, Kenneth W
• Bymaster, Frank P

Titel

The Discovery of Fluoxetine Hydrochloride (Prozac)

Ist Teil von

• Nature reviews. Drug discovery, 2005-09, Vol.4 (9), p.764-774

Ort / Verlag

London: Nature Publishing Group

Erscheinungsjahr

2005

Quelle

Alma/SFX Local Collection

Beschreibungen/Notizen

• In the early 1970s, evidence of the role of serotonin (5-hydroxytryptamine or 5-HT) in depression began to emerge and the hypothesis that enhancing 5-HT neurotransmission would be a viable mechanism to mediate antidepressant response was put forward. On the basis of this hypothesis, efforts to develop agents that inhibit the uptake of 5-HT from the synaptic cleft were initiated. These studies led to the discovery and development of the selective serotonin-reuptake inhibitor fluoxetine hydrochloride (Prozac; Eli Lilly), which was approved for the treatment of depression by the US FDA in 1987. Here, we summarize this research and discuss the many challenges that we encountered during the development of fluoxetine hydrochloride, which has now been widely acknowledged as a breakthrough drug for depression.